Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the Reliance SARS-CoV-2/FluA/FluB™ RT-PCR Kit (IVD) for European markets after having met the CE-IVD mark requirements.
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.
Telephone: +44 (0)1223 968 920
Stirling House, Cambridge Innovation Park, Denny End Road, Waterbeach, Cambridge
Post Code: CB25 9QE
Country: United Kingdom
Membership Type: Corporate 6-20